|
1000
|
Verantwortlich
|
-
NHR - Oxford Biomedical Research Centre, HM Government, CEPI, Public Health England, oxford vaccine group, University of Oxford, NISEC, COM-COV - Comparing COVID-19 Vaccine Schedule Combinations, COV-BOOST - Evaluating COVID-19 vaccine boosters, University Hospital Southampton ; Professor Matthew Snape ; VACCELERATE
|
|
1000
|
Abstract/Summary
|
-
The Oxford Vaccine Group’s vaccine trials have delivered important data on the combination of approved COVID-19 vaccines for first and second immunization doses. The Com-Cov1 study investigates the safety and immune responses of COVID-19 vaccines that are potentially to be deployed in the UK. The Com-COV2 study follows on and works in parallel with the Com-COV1 approach to answer the same questions, but involving different vaccines. Both studies include persons aged 50 and over. One important question is that of ‘mixed’ schedules. This is important, as being able to use different vaccines in this way creates a more flexible immunization program. COM-COV is led by Prof. Matthew Snape and delivered by a network of trial sites across the UK. VACCELERATE, the EU funded clinical research network for the coordination & conduct of COVID-19 vaccine trials is looking forward to host this webinar. Prof. Matthew Snape and his colleague Emma Plested will present the studies and their goals and give insights into the results on vaccination reactions, effectiveness and the time gap between the doses.
|
